Professor Christoph Wanner - Renoprotective effects of SGLT2 inhibitors
30:05
Professor David Wheeler - Renoprotective effects of SGLT2 inhibitors
35:24
Professor David Wheeler - 'How do SGLT2 inhibitors benefit the kidney?'
11:19
EHJ Today - The EMPA-REG OUTCOME Trial
1:26:00
Chronic Kidney Disease (CKD) | Clinical Medicine
56:22
"SGLT2 Inhibitors: Mechanisms of Behind the Mortality Benefit" presented by Amy Li
25:34
Professor Peter Libby
28:18
Debate a new era in the management of type 2 diabetes & cardiorenal disease
27:36